BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,124 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,187,548 | +220.4% | 163,952 | +286.8% | 0.07% | +260.0% |
| Q2 2023 | $1,931,243 | +3.7% | 42,389 | -7.6% | 0.02% | 0.0% |
| Q1 2023 | $1,861,663 | -23.6% | 45,899 | -4.0% | 0.02% | -23.1% |
| Q4 2022 | $2,437,283 | -16.6% | 47,818 | -11.8% | 0.03% | -23.5% |
| Q3 2022 | $2,921,000 | -12.7% | 54,228 | +4.1% | 0.03% | -8.1% |
| Q2 2022 | $3,345,000 | -18.7% | 52,073 | -1.8% | 0.04% | 0.0% |
| Q1 2022 | $4,113,000 | -11.8% | 53,045 | -2.4% | 0.04% | -7.5% |
| Q4 2021 | $4,665,000 | -5.6% | 54,348 | -11.5% | 0.04% | -9.1% |
| Q3 2021 | $4,941,000 | +4.5% | 61,438 | +4.7% | 0.04% | +10.0% |
| Q2 2021 | $4,726,000 | -7.4% | 58,704 | -3.0% | 0.04% | -11.1% |
| Q1 2021 | $5,103,000 | +3.9% | 60,504 | -1.1% | 0.04% | -2.2% |
| Q4 2020 | $4,911,000 | -1.5% | 61,204 | -1.3% | 0.05% | -16.4% |
| Q3 2020 | $4,987,000 | -12.2% | 62,010 | -6.0% | 0.06% | -15.4% |
| Q2 2020 | $5,678,000 | -19.3% | 65,947 | -23.9% | 0.06% | -21.7% |
| Q1 2020 | $7,036,000 | -5.0% | 86,657 | -2.2% | 0.08% | +40.7% |
| Q4 2019 | $7,406,000 | -5.2% | 88,569 | -0.8% | 0.06% | -9.2% |
| Q3 2019 | $7,811,000 | +0.2% | 89,295 | -6.2% | 0.06% | +10.2% |
| Q2 2019 | $7,796,000 | -3.6% | 95,195 | -4.3% | 0.06% | -4.8% |
| Q1 2019 | $8,085,000 | +16.7% | 99,435 | -5.5% | 0.06% | +5.1% |
| Q4 2018 | $6,928,000 | -1.8% | 105,250 | +15.0% | 0.06% | +22.9% |
| Q3 2018 | $7,058,000 | +2.3% | 91,550 | -2.0% | 0.05% | +2.1% |
| Q2 2018 | $6,900,000 | +10.2% | 93,450 | -3.0% | 0.05% | +11.9% |
| Q1 2018 | $6,263,000 | -2.0% | 96,300 | -2.6% | 0.04% | +5.0% |
| Q4 2017 | $6,393,000 | -14.6% | 98,900 | -17.1% | 0.04% | -13.0% |
| Q3 2017 | $7,486,000 | +3.7% | 119,300 | 0.0% | 0.05% | 0.0% |
| Q2 2017 | $7,222,000 | +16.4% | 119,300 | -0.3% | 0.05% | +17.9% |
| Q1 2017 | $6,202,000 | +15.7% | 119,600 | -1.1% | 0.04% | +14.7% |
| Q4 2016 | $5,361,000 | -8.8% | 120,900 | -2.1% | 0.03% | -10.5% |
| Q3 2016 | $5,879,000 | +3.9% | 123,500 | -1.3% | 0.04% | +2.7% |
| Q2 2016 | $5,657,000 | -10.4% | 125,100 | -18.6% | 0.04% | -11.9% |
| Q1 2016 | $6,316,000 | +5.5% | 153,750 | -2.0% | 0.04% | +7.7% |
| Q4 2015 | $5,986,000 | +15.4% | 156,900 | -0.6% | 0.04% | +14.7% |
| Q3 2015 | $5,185,000 | -59.7% | 157,850 | -14.2% | 0.03% | -51.4% |
| Q2 2015 | $12,864,000 | +13.9% | 183,950 | +11.6% | 0.07% | +18.6% |
| Q1 2015 | $11,292,000 | -10.9% | 164,850 | -4.7% | 0.06% | -10.6% |
| Q4 2014 | $12,672,000 | -21.5% | 172,900 | -23.1% | 0.07% | -24.1% |
| Q3 2014 | $16,144,000 | -8.3% | 224,940 | -7.6% | 0.09% | -5.4% |
| Q2 2014 | $17,598,000 | +6.1% | 243,400 | +7.9% | 0.09% | +2.2% |
| Q1 2014 | $16,592,000 | +4.7% | 225,500 | -1.0% | 0.09% | +5.9% |
| Q4 2013 | $15,847,000 | +0.1% | 227,850 | -5.4% | 0.08% | -8.6% |
| Q3 2013 | $15,825,000 | -6.7% | 240,900 | -1.7% | 0.09% | -13.1% |
| Q2 2013 | $16,968,000 | – | 244,950 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |